Larger studies with larger sample size, more extensive immunophenotypic panel, cytogenetics and follow up survival analysis needs to be done in Indian setup to clearly understand the biology of expression of CD34 in B-ALL and thus paves the way for future research. This evidence concerns the gene CD34 and acute lymphoblastic leukemia.